Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Search content at Oregon Health & Science University
Home
Profiles
Research units
Core Facilities
Publications
End points for therapeutic trials for BPD
Judy L. Aschner
,
Cynthia C.T. McEvoy
Pediatrics
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'End points for therapeutic trials for BPD'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bronchopulmonary Dysplasia
100%
Therapeutic Trial
100%
Intervention Studies
50%
Disease Severity
50%
Scoring System
50%
Lung Health
50%
High Sensitivity
50%
High Specificity
50%
Hospital Discharge
50%
Drug Development
50%
Regulatory Agencies
50%
Contemporary Practice
50%
Prognostic Biomarker
50%
Parenchymal Disease
50%
Therapeutic Discovery
50%
Hospital Discharge Outcome
50%
Respiratory Scoring
50%
Post-hospital Discharge
50%
Medicine and Dentistry
Lung Dysplasia
100%
Clinician
50%
Sensitivity and Specificity
50%
Disease Severity
50%
Scoring System
50%
Intervention Trial
50%
Biological Marker
50%
Lung
50%